Guglielmo Trovato

Prof. Dr. Guglielmo Trovato

orcid

Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2015 in Liver International
Verified
Journal Article
Closed access
PDF file
FTFrancesca Maria Trovato
Francesca Maria Trovato
GMGiuseppe Fabio Martines
Giuseppe Fabio Martines
DBDaniela Brischetto
Daniela Brischetto
DCDaniela Catalano
Daniela Catalano
Giuseppe MusumeciGiuseppe Musumeci
Giuseppe Musumeci
Guglielmo TrovatoGuglielmo Trovato
Guglielmo Trovato

1 February 2015 in Clinical Nutrition
Verified
Journal Article
Closed access
FTFrancesca Maria Trovato
Francesca Maria Trovato
DCDaniela Catalano
Daniela Catalano
GMG. Fabio Martines
G. Fabio Martines
PPPatrizia Pace
Patrizia Pace
Guglielmo TrovatoGuglielmo Trovato
Guglielmo Trovato

5 February 2014 in La radiologia medica
Verified
Journal Article
Closed access
PDF file
Marco SperandeoMarco Sperandeo
Marco Sperandeo
ARAntonio Rotondo
Antonio Rotondo
GGGiuseppe Guglielmi
Giuseppe Guglielmi
DCDaniela Catalano
Daniela Catalano
BFBeatrice Feragalli
Beatrice Feragalli
Guglielmo TrovatoGuglielmo Trovato
Guglielmo Trovato

18 February 2010 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
DCDaniela Catalano
Daniela Catalano
GMGiuseppe Fabio Martines
Giuseppe Fabio Martines
ATAntonia Tonzuso
Antonia Tonzuso
CPClara Pirri
Clara Pirri
FTFrancesca Maria Trovato
Francesca Maria Trovato
Guglielmo TrovatoGuglielmo Trovato
Guglielmo Trovato

23 June 2015 in Scandinavian Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
MSM Sperandeo
M Sperandeo
ACA De Cata
A De Cata
FMF Molinaro
F Molinaro
FTFrancesca Maria Trovato
Francesca Maria Trovato
DCD Catalano
D Catalano
Guglielmo TrovatoGuglielmo Trovato
Guglielmo Trovato
Objectives: Systemic sclerosis (SSc) patients in the early stages of pulmonary fibrosis (PF) often have few or no symptoms, normal to borderline pulmonary function tests, and negative chest X-ray (CXR); high-resolution computed tomography (HRCT) is the only reliable means of detecting the early signs of PF. However, thoracic ultrasound (TUS) enables detection of pleural thickening, pleural/subpleural nodules, and other subpleural lung abnormalities across 70% of the subpleural surface. We reassessed concordance between TUS abnormalities and HRCT findings in SSc patients, to see whether TUS pleural line thickness (normally < 3.0 mm) could be used to earmark those with asymptomatic PF for timely HRCT assessment. Method: In total, 175 SSc patients (nine males, 166 females), aged 46.46 ± 15.33 years, were given CXR, TUS, HRCT, echocardiography, and pulmonary function tests. Results: In the 26 patients without HRCT signs of PF, pleural line thickness was ≤ 3.0 mm. In diffuse SSc, 97/137 patients showed pleural line thickening (between 3.0 and 5 mm) and subpleural nodules in 32/97; and 35/137 showed major pleural line thickening (≥ 5.0 mm) with nodules, with good concordance with HRCT patterns indicating lung fibrosis severity. HRCT was normal in 5/137, with pleural line thickness ≤ 3.0 mm. Conclusions: TUS imaging of pleural/subpleural structures can detect ultrasonographic signs of initial PF prior to the onset of respiratory symptoms and function test abnormalities and, together with current criteria, could thereby enable exclusion of PF in SSc patients. Indicating some patients for selective referral to HRCT can thereby delay unwarranted procedures, provided that pulmonary function and TUS images are stable.

29 September 2009 in International Journal of Obesity
Verified
Journal Article
Closed access
Guglielmo TrovatoGuglielmo Trovato
Guglielmo Trovato
ACA Castro
A Castro
ATA Tonzuso
A Tonzuso
AGAdriana Garozzo
Adriana Garozzo
GMG F Martines
G F Martines
DCD Catalano
D Catalano